Agent Orange Exposure Now Linked to MDS Blood Cancer in Vietnam Veterans, Study Confirms

A new study provides the first clear evidence linking exposure to Agent Orange, the notorious herbicide used during the Vietnam War, to the development of myelodysplastic syndromes (MDS), a group of aggressive blood cancers. For decades, veterans have presented with MDS, but a definitive causal connection to the toxic defoliant had remained unproven. Research published this month in *Blood Advances* now establishes that link, showing the exposure can trigger earlier onset and more severe forms of the disease.

The work, led by hematologist-oncologist Mikkael Sekeres, stemmed from clinical observations of veterans in his care who had been exposed to Agent Orange and later developed MDS. While the herbicide has long been associated with numerous other cancers and serious illnesses, MDS was a glaring omission from the list of recognized conditions. The new data closes that gap, offering veterans and their families a long-sought scientific basis for their health struggles.

This finding has immediate and significant implications for veterans' healthcare and benefits. It adds substantial weight to ongoing efforts to have MDS formally recognized by the U.S. Department of Veterans Affairs as a service-connected condition presumptively caused by Agent Orange. Such a designation would streamline access to critical medical care and disability compensation for affected veterans, addressing a health legacy that has persisted for over half a century.